Stockholders Equity (Details) $ / shares in Units, $ in Thousands |
1 Months Ended | 6 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2020 |
Mar. 30, 2021 |
Jun. 30, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2020
shares
|
Dec. 31, 2019
$ / shares
|
Mar. 10, 2021
shares
|
Jan. 01, 2021
shares
|
Jan. 01, 2020
shares
|
Nov. 30, 2017
shares
|
May 31, 2017
$ / shares
shares
|
|
| Stockholders Equity (Details) [Line Items] | ||||||||||
| Market sales agreement, description | pursuant to a registration statement on Form S-3 declared effective by the Securities and Exchange Commission on December 11, 2020, the Company entered into an Open Market Sales Agreement (“ATM Agreement”) with Jefferies LLC. (“Jefferies”), which provides that, upon the terms and subject to the conditions and limitations in the ATM Agreement, the Company may elect, from time to time, to offer and sell shares of Common Stock with an aggregate offering price of up to $50,000, with Jefferies acting as sales agent. During the six months ended June 30, 2021, the Company sold 734,164 shares of Common Stock under the ATM Agreement, at an average price of $6.99 per share, raising aggregate net proceeds of approximately $5,135, after deducting an aggregate commission of $158. | |||||||||
| Number of shares available to grant | 1,846,554 | |||||||||
| Vesting period | 4 years | |||||||||
| Fair value at the grant date (in Dollars) | $ | $ 5,138 | |||||||||
| Shares of issued warrants | 362,444 | |||||||||
| Shares, Issued | 362,383 | |||||||||
| Warrants were fully vested and exercisable | 236,552 | 118,277 | ||||||||
| Warrants cancelled | 236,553 | |||||||||
| New Incentive Plan [Member] | ||||||||||
| Stockholders Equity (Details) [Line Items] | ||||||||||
| Grant options (in Dollars per share) | $ / shares | $ 1,000 | |||||||||
| Stock Options [Member] | ||||||||||
| Stockholders Equity (Details) [Line Items] | ||||||||||
| Grant approved | 985,530 | |||||||||
| Exercise price (in Dollars per share) | $ / shares | $ 7.02 | |||||||||
| 2019 Plan [Member] | ||||||||||
| Stockholders Equity (Details) [Line Items] | ||||||||||
| Number of shares available to grant | 930,813 | 914,741 | ||||||||
| Yeda [Member] | ||||||||||
| Stockholders Equity (Details) [Line Items] | ||||||||||
| Shares of issued warrants | 7,615 | |||||||||
| Scientific Founders [Member] | ||||||||||
| Stockholders Equity (Details) [Line Items] | ||||||||||
| Shares of issued warrants | 2,974 | |||||||||
| License Agreement [Member] | ||||||||||
| Stockholders Equity (Details) [Line Items] | ||||||||||
| Warrants to purchase common stock | 591,382 | |||||||||
| Common stock nominal value (in Dollars per share) | $ / shares | $ 0.0001 | |||||||||